Tokyo, Japan and Cambridge, UK, 14 February 2025 - Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

Hydro's adjusted EBITDA for the fourth quarter of 2024 was NOK 7,701 million, up from NOK 3,737 million in the same quarter last year. The results increased from higher alumina and all-in aluminium pr ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

IDF strikes launcher * US signals backing for Israeli forces staying in 5 southern Lebanon posts after Feb. 18 * Hamas set to ...

For some, Ivanpah now stands as a huge, shiny monument to wasted tax dollars and environmental damage. For others, failures ...

Three out of four prospective electric vehicle (EV) drivers believe signage around public chargers should turn green to help ...